The human body has many ways of protecting itself from getting sick, especially from viruses like influenza, which most people just call the flu. The immune system is responsible for this protection and fights infections in two main ways: active immunity and passive immunity. Both work to protect the body in different ways. One takes longer to build up but lasts longer, while the other works almost immediately but doesn’t last as long. Looking at how both of these work with the flu can help explain why we use both vaccines and antibody treatments instead of just one. 

Passive immunity is almost like borrowing protection instead of creating it yourself. Instead of your body producing its own antibodies, they are basically given to you from another source. These types of antibodies are usually created in labs as monoclonal antibodies designed to target the specific parts of the flu virus. Doctors will typically use these antibodies during severe outbreaks or for people who are more susceptible or vulnerable to illness, such as older adults or people with weaker immune systems (Sparrow et al., 2016). One major advantage of passive immunity is that it begins working almost immediately, and this is important because if someone has already been exposed to the virus, it may be able to hold it off for a little longer. In addition, the treatment is very useful in situations where vaccines might not be ready yet or don’t quite work as well for certain people (Berry, 2017). 

Once inside the body, these antibodies work by recognizing specific proteins on the surface of the flu virus. After they attach to the virus, they can block it from entering healthy cells or help destroy infected cells (Rudraraju & Subbarao, 2018). As a result, they reduce the spread of the virus and can lessen its severity overall. Passive immunity can be used both before exposure and after infection, making it a useful option in different situations. 

However, even though passive immunity works fast, it doesn’t last very long. Since the body isn’t producing its own antibodies, it’s not actually learning how to fight the virus. That means that, once the antibodies fully break down and disappear, the protection leaves too. This is one of the biggest downsides to passive immunity. Because of that, passive immunity is more of a short-term solution instead of something that protects you long-term. This is where active immunity plays a critical role in long-term defense against the flu.

Active immunity is what people think about when they hear about the immune system, especially because of vaccines. This happens when your body is exposed to a virus, or something like it, and then learns how to fight it by itself. With the flu, this usually comes from getting a flu shot. The vaccine contains weakened or even inactive parts of the virus, so it doesn’t make you sick, but still lets your immune system adapt to it and be able to recognize and fight it. 

After getting vaccinated, your body begins producing antibodies of its own that specifically recognize the flu virus (Wall et al., 2021). It also creates memory B and T cells, which allow the immune system to respond more quickly and effectively if the virus is encountered again. This is why active immunity provides a longer-lasting protection compared to passive immunity. Although it takes more time to develop, it becomes more reliable long-term.

Even though vaccines are helpful, they are not perfect. The flu virus changes a lot over time, which makes things a bit harder. This is called antigenic drift, and it essentially means that the virus mutates little by little over time. Because of this, scientists need to update the flu vaccine every year. There is also research being done to try to create a universal flu vaccine that would work against many different strains by targeting certain parts of the virus that don’t really change as much (Zhang et al., 2025).

Scientists have also found that antibodies can target different parts of the flu virus, not just one. Some target hemagglutinin, while others target neuraminidase. Having antibodies that recognize multiple parts of the virus can strongly improve the overall protection (Eichelberger & Wan, 2024). This can happen through vaccines or antibody treatments, showing that both types of immunity can be useful in different ways. 

When comparing active and passive immunity, the biggest differences are how quickly they work and how long they last. Passive immunity provides immediate protection but only for a short period of time. In contrast, active immunity takes longer to develop, but it provides a longer-lasting protection because the body is able to learn how to fight the virus off by itself. Both types are important and are used in different situations depending on the specific needs of the individual. 

Overall, active and passive immunity both play important roles in protecting people from the flu. Vaccines help build long-term protection, while antibody treatments can provide immediate protection when needed. Even though neither one is perfect on its own, they are most effective when used together. Understanding how these two types of immunity work helps explain how modern medicine protects people from viruses like the flu. 

References

Zhang, X., & Ross, T. M. (2024). Anti-neuraminidase immunity in the combat against influenza. Expert review of vaccines, 23(1), 474–484. https://doi.org/10.1080/14760584.2024.2343689

Berry C. M. (2018). Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?. Human vaccines & immunotherapeutics, 14(3), 796–799. https://doi.org/10.1080/21645515.2017.1363135

Li, M., Guo, P., Song, H. et al. Development of universal influenza vaccines: strategies for broadly cross-reactive influenza vaccine responses. Animal Diseases 5, 33 (2025). https://doi.org/10.1186/s44149-025-00187-6

Reber, A., & Katz, J. (2013). Immunological assessment of influenza vaccines and immune correlates of protection. Expert review of vaccines, 12(5), 519–536. https://doi.org/10.1586/erv.13.35

Wall, D. J., Patel, M. M., Chung, J. R., Lee, B., & Dawood, F. S. (2021). Antibody Response and Protection After Receipt of Inactivated Influenza Vaccine: A Systematic Review. Pediatrics, 147(6), e2020019901. https://doi.org/10.1542/peds.2020-019901

Sparrow, E., Friede, M., Sheikh, M., Torvaldsen, S., & Newall, A. T. (2016). Passive immunization for influenza through antibody therapies, a review of the pipeline, challenges and potential applications. Vaccine, 34(45), 5442–5448. https://doi.org/10.1016/j.vaccine.2016.08.057

Rudraraju, R., & Subbarao, K. (2018). Passive immunization with influenza haemagglutinin specific monoclonal antibodies. Human vaccines & immunotherapeutics, 14(11), 2728–2736. https://doi.org/10.1080/21645515.2018.1489947


Poem

The flu arrives like a winter wind,
a thief that slips beneath the skin,
no loud alarm, no warning bell,
just quiet chaos it begins to tell.

But deep inside the body’s gate,
an army learns, it doesn’t wait,
it studies shadows, shape and name,
then builds a fire to match the flame.

A vaccine comes, a practiced guide,
a harmless “ghost,” the cells decide,
a memory carved in silent code,
a map for every viral road.

And when the real storm comes to call,
the body rises, stands up tall,
with antibodies, sharp and fast,
it knows this enemy from the past.

But sometimes battle must begin
before that memory is within,
so borrowed guards are sent ahead,
with borrowed strength and borrowed thread.

These passive soldiers, quick to fight,
like borrowed stars that cut through the night,
they block the virus, hold the line,
but fade away with passing time.

No memory lives within their hand,
they guard, but do not understand,
they fight the war, then drift away,
not built to stay, not built to stay.

So one path learns, and one path lends,
one builds a future, one defends,
and both together, side by side,
help human bodies stay alive.